Skip to main content
ICMR Says More Trials Needed to Demonstrate Mortality Reduction Due to Itolizumab & Tocilizumab - News18 15-Jul-2020
ICMR Says More Trials Needed to Demonstrate Mortality Reduction Due to Itolizumab & Tocilizumab - News18
ICMR Director General Dr Balram Bhargava’s statement came just a day after Biocon Ltd touted its Psoriasis drug Itolizumab as a potentially life-saving drug.
More...